What does 21 CFR 820.45 require for device labeling and packaging inspection?
By Savi C., Co-Founder · Published Nov 16, 2026
Why the QMSR kept a separate labeling section
When the Quality Management System Regulation took effect on February 2, 2026, most of 21 CFR Part 820 was replaced by ISO 13485:2016, incorporated by reference. Labeling and packaging was one of the few areas where FDA kept its own text. Section 820.45 applies in addition to ISO 13485 clause 7.5.1, control of production and service provision.
The section opens with a procedural requirement. Each manufacturer must document and maintain procedures that describe in detail the activities that ensure the integrity, inspection, storage and operations for labeling and packaging, under the customary conditions of processing, storage, handling, distribution and, as appropriate, use of the device. It then sets three specific obligations, in paragraphs (a), (b) and (c).
What each paragraph of 820.45 requires
Paragraph
Introductory text
Requirement
Documented procedures covering integrity, inspection, storage and operations for labeling and packaging, under customary processing, storage, handling, distribution and use conditions
Paragraph
820.45(a)
Requirement
Labeling and packaging examined for accuracy before release or storage, where applicable, including the correct UDI or UPC or other device identification, expiration date, storage instructions, handling instructions and any additional processing instructions
Paragraph
820.45(b)
Requirement
The release of labeling for use documented in accordance with ISO 13485 clause 4.2.5, control of records
Paragraph
820.45(c)
Requirement
Labeling and packaging operations established and maintained to prevent mix-ups, including inspection before use to assure all devices have correct labeling and packaging as specified in the medical device file, with results documented under clause 4.2.5
What the text does not say
The regulation does not prescribe a specific method, so line clearance, label reconciliation and vision systems are ways of meeting 820.45 rather than requirements written into it. Many manufacturers still use them, because they are practical evidence that mix-ups were prevented. The QMSR text states the outcome and leaves the method to your procedures.
The reference point for "correct" labeling is now the medical device file, the ISO 13485 clause 4.2.3 term that replaced the device master record. If the approved label content lives in a document outside the medical device file, inspectors may ask how the inspection proved anything.
Labeling and packaging inspection checklist
Before labeling is released for use
- Label revision matches the revision listed in the medical device file for this device
- UDI or UPC on the label matches the device identifier assigned to this version or model
- Expiration date on the label matches the dating rule for the lot
- Storage, handling and any additional processing instructions match the approved content
- Release of the labeling for use documented, as 820.45(b) requires, with who released it and when
At the line, before use
- Previous product labeling removed from the line and the clearance recorded
- Labels at the station match the work order, product and lot being packaged
- First-article or start-up label inspection recorded before production runs
In the record for each device or batch
- Results of the labeling inspection present and signed, as 820.45(c) requires
- Labels issued, applied, destroyed and returned reconciled, with any discrepancy investigated
- The UDI recorded for the device or batch, as 820.35(c) requires
How Litewave fits
Labeling evidence is scattered across the record for each device or batch: label printouts, line clearance forms, reconciliation counts and inspection signatures. Litewave reads paper or electronic records, checks every entry against your master record and specifications, and shows QA only the exceptions, each linked to the page it came from. Litewave proposes, qualified people approve. Our published results come from pharmaceutical manufacturing, and device figures will be published only when a device customer has agreed to them. For the full device record review, see the guide DHR review checklist under the FDA QMSR.
Questions we get asked
Does 820.45 require 100% label inspection?
The text requires labeling and packaging to be examined for accuracy before release or storage, and inspected before use to assure all devices have correct labeling. It does not set a sampling plan. The method your procedure chooses has to be able to show that every device was correctly labeled, and you should be ready to justify it.
Is 820.45 covered by ISO 13485 certification?
No. 820.45 is an FDA requirement added on top of ISO 13485 clause 7.5.1. A certification audit against ISO 13485 does not assess it, but FDA inspects against it.
Where do labeling inspection results have to be kept?
820.45 requires the results, and the release of labeling for use, to be documented in accordance with ISO 13485 clause 4.2.5, control of records. Most manufacturers keep them in, or linked from, the record for each device or batch, so the review before release can confirm them.
